JPRN-UMIN000040550招募中未知
Sugammadex dosing based on ideal or actual body weight in underweight patients - Sugammadex dosing based on ideal or actual body weight in underweight patients
ihon University School of Medicine0 个研究点目标入组 32 人开始时间: 2021年5月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patient who is allergic to muscle relaxants patient who has neuromuscular diseases patient who has moderate to severe liver function failure
研究者
相似试验
招募中
1 期
Sugammadex dosing based on ideal or actual body weight in underweight patients.Patients undergoing general anesthesiaJPRN-jRCT1031230452Sato Hanae32
Unknown
3 期
Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular BlockadeNeuromuscular BlockadeNCT01855217St. Antonius Hospital25
已完成
3 期
Sugammadex-dosing in Bariatric PatientsNeuromuscular BlockadeNCT01570179Central Hospital, Nancy, France34
已完成
不适用
Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium.Patients scheduled for elective surgery requiring general anesthesiaJPRN-UMIN000025218Department of Anesthesiology Nihon University School of Medicine40
已完成
2 期
Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese PatientsMorbid ObesityNCT02545595Poitiers University Hospital